TG Therapeutics | Capital Ordinário





Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Alaunos Therapeutics USD 2.21M 2.2M 2025-09
Amgen USD 538M 300K 2025-09
Ardelyx USD 238.02M 1.13M 2024-12
Arrowhead Research USD 135.7M 2.44M 2025-09
Bayer EUR 982.42M 0 2025-09
Biogen USD 146.7M 200K 2025-09
Corcept Therapeutics USD 105.12M 164K 2025-09
Dynavax Technologies USD 117.23M 117.11M 2025-06
Gilead Sciences USD 1.24B 0 2025-09
J&J USD 2.41B 584K 2025-09
Novartis USD 1.94B 23.4M 2025-06
PTC Therapeutics USD 79.93M 554K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
TG Therapeutics USD 155.21M 2.81M 2025-09
Vertex Pharmaceuticals USD 254M 2.29M 2025-09


TG Therapeutics Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.